There have been some attempts to separate out Vanessa's Law and say that there's no cost to it. What we are saying is that there are six major changes rooted in this redefinition of NHPs as therapeutic products. The six major changes—two legislative and the others regulatory—make it very hard for a small company to stay competitive and to compete with the big guys. We have two very big guys in Canada, and a few medium guys. The rest are small, and there are a lot of micros. We can look at indigenous businesses in that space, as well. I think they are smaller than what would be defined as a micro NHP company. It becomes very hard to stay afloat. It becomes very hard to even stay competitive.
When you walk into a natural health food store to buy.... I'll use vitamin C, because it's well known. There's a reason there isn't just one. There are many options in vitamin C. There is no patent IP protection on NHPs. You spend on innovation. You spend on research. You put a product out. Someone can copy that product tomorrow, and it will be on the shelf right beside yours. To stay competitive, prices have to stay within a range people can afford. You can't price yourself out of the market.
What's happening in the States is that they're not facing this regulatory burden. It's a lot cheaper to operate. Even with the exchange rate, you can sell your products into Canada online on the 90-day importation at a much lower cost. The Canadian consumer, unknowingly, is going for the product they can afford. It's available to them. It ships to their door. In the meantime, we're losing jobs, production and retail here in Canada.